Sign In
Sign Out
My Account
Subscribe
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
Special reports
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
Home
»
Authors
»
Trista Morrison
Articles by Trista Morrison
Sofinnova Closes $375M Fund To Support Spinouts
Nov. 15, 2006
By
Trista Morrison
Vasogen Brings In $20.3M To Fund Celacade, VP025 Programs
Nov. 10, 2006
By
Trista Morrison
Bradley Licenses U.S. Rights To BioSante's Bio-E-Gel Product
Nov. 9, 2006
By
Trista Morrison
Bradley Licenses U.S. Rights To BioSante's Bio-E-Gel Product
Nov. 9, 2006
By
Trista Morrison
Celgene Raises $1B As Part Of Addition To S&P 500 Index
Nov. 7, 2006
By
Trista Morrison
Celgene Raises $1B As Part Of Addition To S&P 500 Index
Nov. 7, 2006
By
Trista Morrison
Exelixis' Stock Falls After XL999 Phase II Suspension
Nov. 3, 2006
By
Trista Morrison
Exelixis' Stock Falls After XL999 Phase II Suspension
Nov. 3, 2006
By
Trista Morrison
Critical Therapeutics Gets $20M, Bets On Zileuton CR
Nov. 2, 2006
By
Trista Morrison
Critical Therapeutics Gets $20M, Bets On Zileuton CR
Nov. 2, 2006
By
Trista Morrison
Previous
1
2
…
126
127
128
129
130
131
132
133
134
Next
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe